HLA-B* 5701 Genotyping

Abacavir is a core part of anti retroviral therapy used for the treatment of HIV. Patients with a HLA-B*5701 allele can have increased hypersensitivity to abacavir. In order to avoid the hypersensitivity in these patients, it is important to conduct HLA-B* 5701 genotyping prior to administration of Abacavir.


CAP Accreditation : 9007683   
CLIA Accreditation : 34D2205781